Polycystic Kidney Disease
11
5
5
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Early PKD Observational Cohort Study
Descriptive Analysis of Preimplantation Genetic Test (PGT)in Couples With Polycystic Kidney Disease (PKD). In the ADPKD Subgroup Evaluation of Outcomes and Complications Comparing Couples in Which the Father is Affected With Couples in Which the Mother is Affected
Polycystic Kidney Disease Data Repository
Well-Formulated Ketogenic Diet Polycystic Kidney Disease
PKD Clinical and Translational Core Study
Amnioinfusion for Fetal Renal Failure
Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Evaluation of Gut Bacteria in Patients With Polycystic Kidney Disease
Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease